DMT biz dev Entheon Biomedical (ENBI.C) is going all-in on the DMT (dimethyltryptamine) game. They are the only DMT-focused company targeting addiction. The company is pre-revenue with phase 1…
entheon biomedical
Schizophrenia In January, the Berlin-based psychedelics giant ATAI Life Sciences purchased a majority stake in Recogify – a company researching drugs to combat ailments associated with schizophrenia. The…